InfuSystem Holdings, Inc. (INFU)
NYSEAMERICAN: INFU · Real-Time Price · USD
13.69
+0.13 (0.96%)
Nov 6, 2026, 4:00 PM EST - Market closed

InfuSystem Holdings Revenue

InfuSystem Holdings had revenue of $37.59M in the quarter ending September 30, 2026, with 3.02% growth. This brings the company's total for the last twelve months to $144.44M, up 2.40% year-over-year. In the year 2025, InfuSystem Holdings had annual revenue of $143.44M with 6.36% growth. That makes InfuSystem Holdings the 19,883rd largest company in the world by revenue and 3,070th in the United States.

Revenue (ttm)
$144.44M
Revenue Growth
+2.40%
P/S Ratio
1.90
Revenue / Employee
$305,362
Employees
473
Market Cap
274.19M

Revenue Chart

Revenue by Segment

  • Patient Services 86.53M 57.4%
  • Device Solutions 64.10M 42.6%
Fiscal year ended Dec 31, 2025 See the full InfuSystem Holdings breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025143.44M8.58M6.36%
Dec 31, 2024134.86M9.08M7.22%
Dec 31, 2023125.79M15.87M14.44%
Dec 31, 2022109.91M7.53M7.36%
Dec 31, 2021102.38M4.99M5.13%
Dec 31, 202097.39M16.27M20.06%
Dec 31, 201981.12M13.98M20.82%
Dec 31, 201867.14M-3.94M-5.54%
Dec 31, 201771.08M580.00K0.82%
Dec 31, 201670.50M-44.00K-0.06%
Dec 31, 201570.54M4.05M6.10%
Dec 31, 201466.49M4.21M6.75%
Dec 31, 201362.28M3.45M5.87%
Dec 31, 201258.83M4.19M7.67%
Dec 31, 201154.64M7.41M15.69%
Dec 31, 201047.23M8.27M21.21%
Dec 31, 200938.96M3.55M10.02%
Dec 31, 200835.42M28.83M438.06%
Dec 31, 20076.58M--
Dec 31, 2006---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Inogen354.30M
Treace Medical Concepts205.31M
Neuronetics159.76M
RxSight121.83M
Standard BioTools84.43M
Electromed73.78M
ClearPoint Neuro45.49M
TriSalus Life Sciences45.08M
Revenue Rankings